Bartter's Syndrome Treatment
The treatment for Bartter's syndrome includes potassium supplements and special diuretic medications, called potassium-sparing diuretics. However, the effects of the supplementation and diuretics are short lived, unless additional treatment with anti-inflammatory medications is undertaken. Treatment is required for the rest of a person's life, unless a kidney transplant is performed.
Treatment for Bartter's syndrome includes:
- Potassium supplements:
- Magnesium supplements
- Potassium-sparing diuretic medications:
- Nonsteroidal anti-inflammatory medications:
- Ibuprofen (Motrin, Advil, Nuprin, NeoProfen)
- Ketoprofen (Actron, Orudis, Oruvail)
- Naproxen (Anaprox, Naprosyn, Aleve)
- Indomethacin (Indocin)
- Kidney transplant
Bartter's Syndrome Questions For Doctor
The following are some important questions to ask before and after the treatment of Bartter's syndrome.
Questions to ask before treatment:
- What are my treatment options?
- Is surgery an option for me?
- What are the risks associated with treatment?
- Do I need to stay in the hospital?
- How long will I be in the hospital?
- What are the complications I should watch for?
- How long will I be on medication?
- What are the potential side effects of my medication?
- Does my medication interact with nonprescription medicines or supplements?
- Should I take my medication with food?
Questions to ask after treatment:
- Do I need to change my diet?
- Do I need to lose weight?
- Are there any medications or supplements I should avoid?
- When can I resume my normal activities?
- When can I return to work?
- How often will I need to see my doctor for checkups?
- What local support and other resources are available?
Bartter's Syndrome Specialist
Physicians from the following specialties evaluate and treat Bartter's syndrome:
Continue to Bartter's Syndrome Complications
- Jest P, Pedersen KE, Klitgaard NA, et al: Angiotensin-converting enzyme inhibition as a therapeutic principle in Bartter's syndrome. Eur J Clin Pharmacol 1991; 41(4): 303-5. 
- Scheinman SJ, Guay-Woodford LM, Thakker RV, Warnock DG: Genetic disorders of renal electrolyte transport. N Engl J Med 1999 Apr 15; 340(15): 1177-87. 
- Vaisbich MH, Fujimura MD, Koch VH. Bartter syndrome: benefits and side effects of long-term treatment. Pediatr Nephrol. 2004 Aug;19(8):858-63.